Company / R&D per Share
HealthEquity R&D per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.53
FY2026
5-year range
$1.01 / $3.05
FY2022-FY2026
Trend
-17.0%
vs FY2025
Sector context
#36 of 108
Health Care
What the data says
At $2.53, HealthEquity's r&d per share ranks #36 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.47 in FY2017 to $3.05 in FY2025.
Based on SEC 10-K filings.
2.53 in FY2026 with a 5-year CAGR of +38.7%.
Declined from $2.83 to $2.53 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- +38.7%
- 10-Year CAGR
- -
Sector benchmark
#36 of 108 in Health CareTop 33% of 108This company $2.53 Sector average $2.07
▼
+21.9% above sector average
Key checks
Key Insights
- In FY2026, r&d per share decreased 17.0% year-over-year.
- Ranks #36 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2025.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $2.53 | -17.0% |
| FY2025 | $3.05 | +7.9% |
| FY2024 | $2.83 | +8.2% |
| FY2023 | $2.61 | +159.8% |
| FY2022 | $1.01 | +103.7% |
| FY2021 | $0.49 | -75.3% |
| FY2020 | $2.00 | +56.7% |
| FY2019 | $1.28 | +116.6% |
| FY2018 | $0.59 | +24.1% |
| FY2017 | $0.47 | +16.2% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026